• Je něco špatně v tomto záznamu ?

The DNA methylome of cervical cells can predict the presence of ovarian cancer

JE. Barrett, A. Jones, I. Evans, D. Reisel, C. Herzog, K. Chindera, M. Kristiansen, OC. Leavy, R. Manchanda, L. Bjørge, M. Zikan, D. Cibula, M. Widschwendter

. 2022 ; 13 (1) : 448. [pub] 20220201

Jazyk angličtina Země Velká Británie

Typ dokumentu časopisecké články, pozorovací studie, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc22011202

The vast majority of epithelial ovarian cancer arises from tissues that are embryologically derived from the Müllerian Duct. Here, we demonstrate that a DNA methylation signature in easy-to-access Müllerian Duct-derived cervical cells from women with and without ovarian cancer (i.e. referred to as the Women's risk IDentification for Ovarian Cancer index or WID-OC-index) is capable of identifying women with an ovarian cancer in the absence of tumour DNA with an AUC of 0.76 and women with an endometrial cancer with an AUC of 0.81. This and the observation that the cervical cell WID-OC-index mimics the epigenetic program of those cells at risk of becoming cancerous in BRCA1/2 germline mutation carriers (i.e. mammary epithelium, fallopian tube fimbriae, prostate) further suggest that the epigenetic misprogramming of cervical cells is an indicator for cancer predisposition. This concept has the potential to advance the field of risk-stratified cancer screening and prevention.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22011202
003      
CZ-PrNML
005      
20220506131246.0
007      
ta
008      
220425s2022 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1038/s41467-021-26615-y $2 doi
035    __
$a (PubMed)35105887
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Barrett, James E $u European Translational Oncology Prevention and Screening (EUTOPS) Institute, 6060, Hall in Tirol, Austria $u Research Institute for Biomedical Aging Research, Universität Innsbruck, 6020, Innsbruck, Austria $u Department of Women's Cancer, UCL EGA Institute for Women's Health, University College London, 74 Huntley Street, London, WC1E 6AU, UK
245    14
$a The DNA methylome of cervical cells can predict the presence of ovarian cancer / $c JE. Barrett, A. Jones, I. Evans, D. Reisel, C. Herzog, K. Chindera, M. Kristiansen, OC. Leavy, R. Manchanda, L. Bjørge, M. Zikan, D. Cibula, M. Widschwendter
520    9_
$a The vast majority of epithelial ovarian cancer arises from tissues that are embryologically derived from the Müllerian Duct. Here, we demonstrate that a DNA methylation signature in easy-to-access Müllerian Duct-derived cervical cells from women with and without ovarian cancer (i.e. referred to as the Women's risk IDentification for Ovarian Cancer index or WID-OC-index) is capable of identifying women with an ovarian cancer in the absence of tumour DNA with an AUC of 0.76 and women with an endometrial cancer with an AUC of 0.81. This and the observation that the cervical cell WID-OC-index mimics the epigenetic program of those cells at risk of becoming cancerous in BRCA1/2 germline mutation carriers (i.e. mammary epithelium, fallopian tube fimbriae, prostate) further suggest that the epigenetic misprogramming of cervical cells is an indicator for cancer predisposition. This concept has the potential to advance the field of risk-stratified cancer screening and prevention.
650    _2
$a protein BRCA1 $x genetika $x metabolismus $7 D019313
650    _2
$a protein BRCA2 $x genetika $x metabolismus $7 D024682
650    _2
$a cervix uteri $x cytologie $x metabolismus $7 D002584
650    12
$a metylace DNA $7 D019175
650    _2
$a epigenom $7 D000081122
650    _2
$a epitel $x metabolismus $7 D004848
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a genetická predispozice k nemoci $7 D020022
650    _2
$a lidé $7 D006801
650    _2
$a nádory vaječníků $x genetika $x metabolismus $7 D010051
655    _2
$a časopisecké články $7 D016428
655    _2
$a pozorovací studie $7 D064888
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Jones, Allison $u Department of Women's Cancer, UCL EGA Institute for Women's Health, University College London, 74 Huntley Street, London, WC1E 6AU, UK
700    1_
$a Evans, Iona $u Department of Women's Cancer, UCL EGA Institute for Women's Health, University College London, 74 Huntley Street, London, WC1E 6AU, UK
700    1_
$a Reisel, Daniel $u Department of Women's Cancer, UCL EGA Institute for Women's Health, University College London, 74 Huntley Street, London, WC1E 6AU, UK
700    1_
$a Herzog, Chiara $u European Translational Oncology Prevention and Screening (EUTOPS) Institute, 6060, Hall in Tirol, Austria $u Research Institute for Biomedical Aging Research, Universität Innsbruck, 6020, Innsbruck, Austria $1 https://orcid.org/000000021572498X
700    1_
$a Chindera, Kantaraja $u Department of Women's Cancer, UCL EGA Institute for Women's Health, University College London, 74 Huntley Street, London, WC1E 6AU, UK
700    1_
$a Kristiansen, Mark $u UCL Genomics, Zayed Centre for Research into Rare Disease in Children, University College London, London, WC1N 1DZ, UK
700    1_
$a Leavy, Olivia C $u Department of Health Sciences, University of Leicester, Leicester, LE1 7RH, UK $u Department of Non-communicable Disease Epidemiology, The London School of Hygiene and Tropical Medicine, London, WC1E 7HT, UK $1 https://orcid.org/0000000215035535
700    1_
$a Manchanda, Ranjit $u Department of Gynaecological Oncology, Barts Health NHS Trust, Royal London Hospital, London, E1 1BB, UK $u Centre for Prevention, Detection & Diagnosis, Wolfson Institute of Population Health, Queen Mary University of London, London, EC1M 6BQ, UK $u Department of Health Services Research, The London School of Hygiene and Tropical Medicine, London, WC1E 7HT, UK
700    1_
$a Bjørge, Line $u Department of Obstetrics and Gynaecology, Haukeland University Hospital, Bergen, Norway $u Centre for Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, Bergen, Norway
700    1_
$a Zikan, Michal $u Hospital Na Bulovce, Prague, Czech Republic $u Department of Obstetrics and Gynecology, General University Hospital in Prague, First Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Cibula, David $u Department of Obstetrics and Gynecology, General University Hospital in Prague, First Faculty of Medicine, Charles University, Prague, Czech Republic $1 https://orcid.org/0000000163879356 $7 jo20000074072
700    1_
$a Widschwendter, Martin $u European Translational Oncology Prevention and Screening (EUTOPS) Institute, 6060, Hall in Tirol, Austria. martin.widschwendter@uibk.ac.at $u Research Institute for Biomedical Aging Research, Universität Innsbruck, 6020, Innsbruck, Austria. martin.widschwendter@uibk.ac.at $u Department of Women's Cancer, UCL EGA Institute for Women's Health, University College London, 74 Huntley Street, London, WC1E 6AU, UK. martin.widschwendter@uibk.ac.at $u Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden. martin.widschwendter@uibk.ac.at
773    0_
$w MED00184850 $t Nature communications $x 2041-1723 $g Roč. 13, č. 1 (2022), s. 448
856    41
$u https://pubmed.ncbi.nlm.nih.gov/35105887 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220425 $b ABA008
991    __
$a 20220506131238 $b ABA008
999    __
$a ok $b bmc $g 1789018 $s 1162400
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 13 $c 1 $d 448 $e 20220201 $i 2041-1723 $m Nature communications $n Nat Commun $x MED00184850
LZP    __
$a Pubmed-20220425

Najít záznam

Citační ukazatele

Možnosti archivace